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Abstract
 
Molecular,  cellular,  and  epidemiologic  findings  sug-
gest that neurohormonal, epigenetic, and microbiologic 
mechanisms may influence risk for obesity by interact-
ing  with  socioenvironmental  factors.  Homeostatic  and 
nonhomeostatic  neural  controls  of  energy  predispose 
people to obesity, and this predisposition may be exag-
gerated by the influence of media, marketing, and sleep 
patterns. Epigenetic gene regulation may account for the 
influence of modifiable early life or maternal exposures 
on obesity risk. Alterations in gut flora caused by infant 
feeding practices or later diet may influence the absorp-
tion and storage of energy. Further exploration of how 
these  molecular-cellular  mechanisms  might  increase 
obesity risk in response to modifiable socioeconomic fac-
tors requires the partnership of laboratory and public 
health researchers.
Introduction
 
We describe components of a novel paradigm for obesity-
related research and public health interventions that are 
designed  to  generate  cross-disciplinary  hypotheses  that 
account for multiple levels of causation from molecular to 
societal. The goals of this approach are to understand the 
causal pathways leading to patterns of obesity in popula-
tions and to identify where interventions that can broadly 
affect the population can be implemented (1). Our focus is 
on the mechanisms that may be useful for understanding 
how  socioenvironmental  factors  interact  with  biological 
processes to affect energy balance. We review neurohor-
monal controls, epigenetics, and microbiologic mechanisms 
in gut flora that may influence risk for obesity.
Neurohormonal Controls
Homeostatic controls
 
The complex neurohormonal systems controlling weight 
and  adiposity  can  be  categorized  as  either  homeostatic 
or nonhomeostatic (2). Parsimonious homeostatic mecha-
nisms provided a survival advantage to people faced with 
periodic starvation. Organisms that could consume, store, 
and  conserve  energy  efficiently  were  likely  to  survive 
and reproduce (3). Although evolution may have selected 
against extreme adiposity (4), the negative feedback sig-
nals against excess intake are insufficient to maintain nor-
mal body weight for most humans who have easy access to 
palatable, calorie-dense foods (5).
 
When provided a diet high in calories, animals prone 
to obesity rapidly increase fat stores (2). Furthermore, 
when obese rats lose weight or have their calorie intake 
restricted,  they  mount  the  same  neurohormonal  drive 
as do lean rats to increase intake and decrease energy 
expenditure,  effectively  defending  obesity  (6,7).  After 
weight loss, the average resting energy expenditure of 
obese people is markedly and persistently reduced (8). 
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These  factors  are  blamed  for  the  weight  regain  that 
occurs in approximately 80% to 90% of obese people who 
have lost weight (8,9).
 
A complex interplay of neurotransmitters, hormones, 
and  metabolites  regulates  food  intake  in  the  brain. 
Metabolic  sensing  neurons  of  the  hypothalamus  and 
other brain areas respond to signals of energy intake, 
demand, or storage including circulating glucose, leptin 
from  adipocytes,  insulin,  ghrelin  from  the  stomach, 
adrenal  steroids,  polypeptide  YY  from  the  intestines, 
fatty acids, ketones, lactate, vagal nerve afferents, and 
intrinsic  neurotransmitters  (5).  Hypothalamic  neurons 
release neurotransmitters that activate either catabolic 
processes  (eg,  a-melanocyte-stimulating  hormone  [a-
MSH], cocaine- and amphetamine-regulated transcript 
[CART], corticotropin-releasing hormone [CRH]) or ana-
bolic processes (eg, neuropeptide Y [NPY], agouti-related 
protein  [AGRP],  orexins)  (10).  Hypothalamic  neurons 
signal broadly to the pituitary, brainstem, midbrain, and 
forebrain. These pathways regulating energy intake and 
expenditure have been demonstrated experimentally in 
animal models and through functional neuroimaging in 
humans (11).
 
The interplay between the sympathetic nervous system 
and leptin signaling is an example of neurohormonal pro-
tection of adiposity. With calorie restriction, sympathetic 
activation releases glucose from glycogen stores and fatty 
acids  from  adipose  tissue.  Adipose  tissue  responds  to 
sympathetic activity by markedly decreasing leptin pro-
duction, which decreases resting energy expenditure and 
increases appetite to replenish fat stores (2). Some rare 
human obesity syndromes are associated with single gene 
defects  within  homeostatic  pathways,  including  leptin 
deficiency,  leptin  receptor  defect,  pro-opiomelanocortin 
(POMC)  deficit  leading  to  impaired  a-MSH  production, 
and a-MSH receptor defects (12).
Nonhomeostatic controls
 
Nonhomeostatic  systems  promote  excess  weight  gain 
through responses to the reward properties of food and 
psychosocial  factors  associated  with  eating  (5).  When  a 
palatable and calorically dense diet is provided, rats eat 
far beyond limits of homeostasis and develop extreme lev-
els of obesity, even rats predisposed to leanness (13). The 
more palatable the diet, the higher the degree of obesity 
and the longer it is sustained (13).
 The  organization  and  function  of  the  human  brain 
is  a  reflection  that  throughout  all  but  the  most  recent 
evolutionary history, obtaining food was a difficult task. 
Complex pathways record past context and the expecta-
tion of reward (14). Reward properties of foods (the stimuli 
that augment the drive to obtain foods) mediate “liking” by 
action at opioid receptors and “wanting” by action at dopa-
minergic receptors. Both of these receptors also mediate 
addiction (4). Metabolic signals modify the sensing thresh-
olds for food-related stimuli, food-seeking behavior, and 
reward signals (4). Chronic stress enhances the reward 
value of foods (15). Although the subcortical areas contrib-
ute to subconscious drives for intake, the cortical areas 
integrate these underlying signals with learned motiva-
tional cues. These cues can drive intake well beyond sub-
cortical demands of energy needs (16). Overall, the drive 
to eat is the result of complex, redundant systems that 
protect  against  starvation,  but  the  systems  are  grossly 
mismatched to the food and activity environment of the 
developed world (17).
Implications of neurohormonal mechanisms for obesity 
and public health
 
The potency of homeostatic and nonhomeostatic forces 
that promote weight gain and prevent weight loss make 
clear  the  value  of  obesity  prevention,  especially  consid-
ering the cost and difficulty of obesity treatment. Many 
socioenvironmental  factors  interact  with  the  neurologic 
drivers of intake, so identifying and intervening on modifi-
able levels to prevent obesity is a challenging task.
 
Sleep  may  play  a  role  in  maintaining  proper  energy 
balance  by  influencing  neurohormonal  controls  (18).  A 
meta-analysis of 30 cross-sectional studies through early 
2008 found an odds ratio for obesity of 1.89 in children 
with short duration of sleep and 1.55 in adults with short 
duration of sleep (19). More recently published longitu-
dinal studies, one with 32 years of follow-up from birth, 
also  found  that  shorter  sleep  times  in  childhood  were 
significantly associated with increased body mass index 
(20,21). Experimental studies of sleep deprivation show 
increased hunger and appetite associated with neurohor-
monal mechanisms that promote intake: decreased levels 
of leptin, increased levels of ghrelin, increased sympathet-
ic tone, and increased cortisol (22). Nonhormonal effects 
of  short  sleep,  such  as  fatigue  and  decreased  volitional 
energy expenditure, may also play a role in the associa-
tion between sleep and obesity. Debate remains about the 
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and interventions to decrease obesity by increasing sleep 
have yet to be reported (23).
 
Media exposure and food marketing either overpower 
homeostatic negative feedback or strongly amplify nonho-
meostatic drivers of intake. Distracting stimuli, such as 
television viewing while eating, strongly increase intake, 
possibly by interfering with neural signals of satiety (24). 
In a controlled experiment, viewing children’s food adver-
tisements caused children to eat much larger portions of 
snack foods compared to children who watched nonfood 
advertisements,  and  the  effect  was  significantly  larger 
on obese children than on normal-weight children (25). 
Marketing often seeks to influence the emotional respons-
es  to  food  (26)  and  succeeds  in  altering  the  perceived 
reward  value  of  foods  (27).  Most  food  advertisements 
targeting preschool children involve fast-food restaurants 
or sweetened cereals. These advertisements associate the 
products with fun and happiness in an attempt to create 
long-term  customers  through  positive  emotional  asso-
ciations with the product (28). The food industry targets 
children at stages of development critical to establishing 
future eating habits (28).
 
Analysis by the National Bureau of Economic Research 
estimated that eliminating fast-food restaurant advertising 
to children would reduce the prevalence of obesity by 18% 
(29). Some governments have restricted television adver-
tising of food products to children, and some advertisers 
have voluntarily restricted advertisements (30). However, 
the  recent  proliferation  of  other  digital  media  sources, 
including  cell  phones,  mobile  music  devices,  broadband 
video, instant messaging, videogames, and virtual worlds, 
has created a “marketing ecosystem” for advertisement of 
food (31,32), and the influence of marketing on intake may 
become more pervasive in the future.
Epigenetics
 
Studies  searching  for  determinants  of  risks  for  obe-
sity and cardiovascular disease have found that genetics 
(33,34) and behavioral exposures (35) explain only part of 
the  risk.  Epigenetic  mechanisms  describe  environment-
gene  interactions  that  may  explain  some  residual  risk. 
The term epigenetics refers to cellular mechanisms that 
affect gene expression without changing DNA sequence 
(36). Epigenetic markings can be inherited and modified 
throughout  the  lifespan  (37).  Epigenetic  modifications 
during critical early periods, such as embryogenesis (38) 
have the most effect on phenotype. Fetal and early life 
exposures  have  been  associated  with  numerous  health 
outcomes later in life, including obesity (39,40). Changes 
to DNA marking and packaging may explain the influ-
ence of the environment on gene expression throughout a 
person’s life and even across generations (41). Evidence is 
mounting from experimental studies in animals and from 
human epidemiologic studies that epigenetic mechanisms 
may affect risk for chronic disease, especially when the 
environment predicted by fetal experience does not match 
the environment later in life (42,43).
Animal models of epigenetics related to obesity
 
Experimental studies have subjected animals to dietary, 
chemical, and stress exposures during prenatal or early 
life that lead to epigenetic changes in gene expression in 
adulthood. The epigenetic changes caused by some expo-
sures are preventable by other agents. Some changes in 
gene expression persist across generations when epigen-
etic markings are incompletely erased during formation of 
the sperm and ova (38). Several animal studies illustrate 
epigenetic influences on obesity.
 
The Agouti (Avy/a) mouse is a well-described model of 
epigenetically  controlled  obesity.  Among  mice  carrying 
1 obese allele (Avy) and 1 nonobese allele (a), those with 
inadequate methylation of the Avy allele develop obesity 
and yellow fur (38). The Avy protein blocks satiety sig-
nals from insulin and leptin on the hypothalamus (37). 
Obesity is amplified through multiple generations of Avy/
a mice, but supplementing the diet with methyl donors 
prevents  this  amplification  (44).  Maternal  ingestion  of 
bisphenol  A  (BPA),  a  chemical  used  in  polycarbonate 
plastic and epoxy resins, decreased methylation of the Avy 
allele in offspring (45). This decrease in methylation did 
not occur when the soy isoflavone genistein or a methyl 
donor, such as folic acid or vitamin B12, was added to the 
BPA-containing diet (45).
 
Rats whose mothers do not eat enough protein during 
pregnancy have decreased methylation and have increased 
expression  of  glucocorticoid  receptors  and  peroxisomal 
proliferator-activated receptor-a in the liver. These chang-
es are associated with components of metabolic syndrome 
including  hypertension,  dyslipidemia,  and  insulin  resis-
tance. Giving mothers folic acid supplements prevented 
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the hypomethylation and normalized the gene expression 
in offspring (46).
 Elevated  reactivity  to  psychological  stress  has  been 
associated with obesity in humans (47). In a model of early 
life stress, rats who are poorly nurtured by their mothers 
develop exaggerated stress responses and poorly nurture 
their own offspring; the pattern is repeated through mul-
tiple  generations  (48).  Poor  nurturing  increases  stress 
reactivity through methylation and de-acetylation of the 
glucocorticoid  receptor  gene  in  the  brain,  decreasing 
receptor production (49). Infusion of histone deacetylase 
inhibitors or “adopting out” offspring to highly nurturing 
mothers prevented these changes (48). Epigenetic record-
ing of early parenting interactions affects the phenotype 
throughout the lifespan in this model (50).
Human evidence supporting epigenetic mechanisms of 
obesity
 
Certain genes may be particularly vulnerable to epi-
genetic changes. Metastable epialleles like the Avy allele 
in  mice  are  subject  to  dramatic  interindividual  differ-
ences  in  methylation  (37).  Imprinted  genes,  for  which 
the allele from 1 parent is normally silenced by meth-
ylation, are at risk of causing functional problems if the 
remaining  copy  is  inappropriately  silenced.  Two  rare 
human obesity syndromes, Prader-Willi and Beckwith-
Wiedemann, can result from inappropriate methylation 
of imprinted genes (38). The search for metastable epial-
leles and imprinted genes affecting obesity in humans is 
of great interest.
 
Several  studies  have  examined  the  effects  of  specific 
exposures on human fetuses or infants. A prospective study 
following 1,100 mother-child pairs from the prenatal period 
examined the effect of several perinatal exposures on obe-
sity at age 3 years: prenatal smoking, excess weight gain 
during pregnancy, breast-feeding for fewer than 12 months, 
and poor infant sleep duration (51). This study found a pro-
gressive increase in risk of obesity with the addition of each 
risk factor (51). A meta-analysis of breast-feeding studies 
found  a  dose-response  effect  of  breast-feeding  duration 
on decreasing obesity prevalence. Each month of breast- 
feeding up to 9 months decreased the risk of obesity at 3 
years by 4%, yielding an odds ratio of 0.68 for overweight 
in those breast-fed longer than 9 months compared with 
infants  who  were  fed  formula  exclusively  (52).  These 
human studies did not include analysis of specific epigene-
tic markers for gene expression, but they suggest that early 
life exposures can have lasting effects on phenotype.
 
One  study  has  demonstrated  epigenetic  changes  in 
human growth-controlling genes associated with adverse 
perinatal events. The Dutch famine of 1944-1945 provides 
a unique opportunity to study humans exposed to well-
defined undernutrition. Adults who were exposed to poor 
nutrition in utero had an increased prevalence of glucose 
intolerance,  dyslipidemia,  early  coronary  heart  disease, 
and obesity (53,54). A recent study of adults who were 
exposed to the Dutch famine early in gestational develop-
ment is reportedly the first to provide empiric support for 
the hypothesis that environmental exposures can cause 
epigenetic changes in humans. The insulin-like growth fac-
tor-2 (IGF-2) gene, which exerts control over fetal growth, 
is imprinted with the maternal allele normally silenced by 
methylation (55). Methylation of IGF-2 was decreased in 
adults who were exposed to famine early in utero compared 
with unaffected siblings and those exposed to famine only 
late in gestation. This was possibly an effect of decreased 
availability of methyl donors such as folate and the amino 
acid methionine during early development (43).
Implications of epigenetic mechanisms for obesity and 
public health
 
If epigenetic modifications that increase risk for obesity 
and chronic diseases occur widely in humans, the implica-
tions for public health interventions could be substantial. 
Epigenetic changes could underlie the increased risk of 
central obesity and cardiovascular disease among adults 
who experienced adverse in utero conditions, but at pres-
ent direct evidence in humans is sparse. Epigenetic modifi-
cations have been proposed as contributors to variation in 
obesity across race, country, and immigrant status (35,56). 
Some prenatal and early life exposures such as smoking, 
inappropriate weight gain during pregnancy, gestational 
diabetes, and early feeding are known targets for interven-
tion, but a modifiable biologic mechanism may provide an 
additional  incentive  to  intervene  early.  Maternal  stress 
or  chemical  exposures  may  be  explored  for  epigenetic 
mechanisms  affecting  human  disease.  Research  related 
to  epigenetics  draws  on  the  expertise  of  multiple  disci-
plines,  including  molecular  biology/genetics,  nutrition, 
environmental  epidemiology,  and  life  course  epidemiol-
ogy. An international scientific initiative, the Alliance for 
the Human Epigenome and Disease (AHEAD), has a goal 
to create a reference map of epigenetic modification sites 
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early in life, such as the National Children’s Study, may 
provide insight into epigenetic mechanisms of obesity and 
chronic disease (58).
Gut Microbiota
 
Differences in intestinal flora may explain some of the 
risk for obesity, yet like epigenetic mechanisms, evidence 
in humans is sparse. The gut microbiota consists of the 
microorganisms, predominantly bacteria, that inhabit the 
gastrointestinal tract. These microbes metabolize other-
wise indigestible components of the diet, and the prod-
ucts of microbial metabolism affect the amount of energy 
absorbed (59). The combined gene pool of gut microorgan-
isms  enables  absorption  of  simple  sugars  from  complex 
polysaccharides and may influence fat storage by modify-
ing lipoprotein lipase activity (60). RNA sequencing has 
been used to study bacterial species in stool samples (61). 
The species-level makeup of gut flora varies from person to 
person, but most analyses related to obesity have focused 
on how the relative proportion of 2 major bacterial divi-
sions, Bacteroidetes and Firmicutes, differ between obese 
and lean people (62).
Animal studies of microbiota and obesity
 
The effect of microbiota on energy absorption and obesity 
has been demonstrated in mice. Germ-free mice have signif-
icantly less body fat than do mice with standard microbiota, 
and  rapidly  gain  weight  after  inoculation  (60).  Obesity-
prone  mice,  in  contrast  to  their  nonobese  siblings,  carry 
microbiota with an enhanced proportion of genes to break 
down polysaccharides, and their stools show increased fer-
mentation  products  and  decreased  residual  calories  (59). 
When gut flora from obese or lean mice were transplanted 
to germ-free mice eating a high-fat, high-sugar diet, those 
receiving microbiota from obese mice gained significantly 
more fat than did those receiving lean mouse flora (59).
Human studies of microbiota and obesity
 
Thus far, human studies regarding the effect of intestinal 
flora have been observational and have had small sample 
sizes. A recent case-control study found gut flora in infancy 
predicted overweight later in childhood (63). Among chil-
dren who were enrolled as newborns, 25 overweight 7-year-
olds were matched with normal-weight controls for multiple 
factors including probiotics supplementation, antibiotic use, 
and breast-feeding duration (63). On average, overweight 
children had lower numbers of the genus Bifidobacterium 
spp. and higher numbers of Staphylococcus aureus in their 
stools during infancy (63). Bifidobacteria are the predomi-
nant  flora  of  breast-fed  infants  and  are  hypothesized  to 
affect weight gain through mucosal host-microbe crosstalk, 
immune regulation, and inflammation (64).
 
Other studies have examined the flora of obese adults. 
Studies of lean and obese twin pairs found a large vari-
ability  among  species  of  bacteria  present,  but  a  core 
group of functional genes was present across participants 
regardless of species type (65). In addition to this “core 
microbiome,”  the  microbiomes  of  obese  twins  contained 
more  genes  involved  in  carbohydrate,  lipid,  and  amino 
acid metabolism (65). A small study followed stool micro-
biota  in  12  obese  people  randomized  to  low-fat  or  low- 
carbohydrate  diets  for  a  year.  Obese  participants  had 
a smaller proportion of Bacteroidetes and a higher pro-
portion  of  Firmicutes  at  baseline.  During  the  study, 
the  proportion  of  Bacteroidetes  steadily  increased  as 
weight  decreased  on  both  diets,  especially  on  the  low- 
carbohydrate diet (66).
Potential implications of gut microbiota for obesity and 
public health
 
Other  reviewers  have  suggested  that  from  a  public 
health perspective, it might be wise to avoid shifting too 
much focus from the known modifiable causes of obesity 
to gut flora (62). With that reasonable caveat, a small con-
stant source of increased energy absorption could have a 
substantial effect on obesity in populations.
 
Throughout  history,  many  cultures  have  used  benefi-
cial microorganisms to create fermented foods containing 
live microorganisms capable of modifying the makeup of 
intestinal flora, such as yogurt, curd, and kefir (62). Wide-
ranging health claims have been made of commercially 
available  probiotics  (live  nonpathogenic  organisms)  and 
prebiotics  (fermentable  substrates  that  enrich  the  gut 
for potentially beneficial organisms). Larger prospective 
studies are required to validate these health claims and 
to evaluate whether experimental changes to gut flora can 
affect obesity (67). The genetic sequencing techniques nec-
essary to carry out this type of research are rapidly evolv-
ing (68). The National Institutes of Health has devoted 
substantial resources to the Human Microbiome Project to 
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study the association of microbiota from the gut and other 
body sites with disease processes (69).
Conclusion
 
A systems approach to the obesity problem necessitates 
research  that  connects  socioenvironmental  factors  with 
biological  processes  related  to  energy  metabolism.  By 
understanding how obesity results from the interaction of 
cellular factors with social factors, we can develop inter-
ventions that include molecular medicine and broad social 
policy. The potential biological drivers of obesity include 
evolutionarily conserved neurobiological mechanisms, epi-
genetic gene-environment interactions, and gut microbio-
ta. These examples show the need for partnership among 
investigators  across  the  spectrum  of  science.  Research 
questions and hypotheses that are cross-disciplinary can 
aid development of interventions to prevent or control obe-
sity at multiple levels.
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